Skip to main content
. 2019 Sep 11;102(1):67–70. doi: 10.1308/rcsann.2019.0111

Table 2.

Patients with recurrent disease.

Patient number Site of recurrence Time of recurrence following primary nephrectomy (months) Timing of secondary surgical resection after diagnosis of recurrence (months) Resection margins Therapeutic details Outcome
2 Local 5 4 Microscopic positive VA, 4 cycles then resection, 6 cycles cyclophosphamide and doxorubicin Alive and well, disease free
5 Lung 2 5 Negative 2 cycles VAC, then 6 cycles VDC due to disease progression then resection. Lung irradiation Died from acute on chronic respiratory failure
6 Local 2 No surgery N/A 2 cycles of neoadjuvant VA, then surgery because of progression. 12 months of individualised treatment after recurrence with cyclophosphamide, doxorubicin, carboplatin and etoposide Alive and well, disease free

VA, vincristine and actinomycin; VAC, vincristine, adriamycin and cyclophosphamide; VDC, vincristine, doxorubicin, cyclophosphamide.